Versartis Inc.

Versartis Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.05
Market Cap
$54.36 M
Shares Outstanding
36.24 M
Public Float
27.58 M

Profile

Address
1020 Marsh Roade
Menlo Park California 94025
United States
Employees -
Website http://www.versartis.com
Updated 09/14/2018
Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L.

Financials

View All

Jay P. Shepard
President, CEO, CFO & Director
Eric L. Dobmeier
Director